Johnson & Johnson (NYSE:JNJ) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 26, Johnson & ...
Johnson & Johnson said on Friday it discontinued a mid-stage study of its experimental drug to treat patients with moderate ...
MedPage Today on MSN
Assisted Reproduction Linked to Child's Risk of Asthma, Eczema
Children conceived through assisted reproductive technology (ART) were modestly more likely to develop asthma, allergic ...
Johnson & Johnson has discontinued a phase 2 trial of one of its pipeline candidates for atopic dermatitis (AD), after it ...
Vietnam Investment Review on MSN
Eczema causes festive isolation for some Singaporeans during gatherings
Skin condition flare-ups during the humid season are leading some individuals to avoid social events and celebrations.
Chip Chick on MSN
She dumped her boyfriend after he was diagnosed with scabies and didn't tell her about it
Scabies is a skin condition caused by mites that get under your skin, causing you to itch. It’s extremely contagious and can ...
A new study published in the journal of Inflammopharmacology showed that in individuals with moderate-to-severe atopic ...
Nemolizumab, which targets the interleukin-31 pathway, rapidly improves itch and sleep in people with atopic dermatitis and ...
Equip health professionals with resources to diagnose and treat conditions across all skin tones. Make mental health support ...
Medical Channel Asia's ongoing eczema survey reveals how chronic itch drives withdrawal, emotional strain, and missed celebrations during a period ...
HealthDay News — Iron deficiency without anemia is a common feature of moderate-to-severe atopic dermatitis (AD), according to a study published in Nutrients.
Stocktwits on MSN
Johnson & Johnson terminates experimental eczema drug study after it fails to show benefit
The drug JNJ-5939 was being evaluated in the treatment of moderate to severe atopic dermatitis in a mid-stage study. ・JNJ, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results